Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/21/2025

Urinary Tract Infection Treatment

Introduction to UTI Treatment

  • Urinary tract infections (UTIs) require evidence-based treatment to prevent complications and promote recovery, as recommended by the Infectious Diseases Society of America and American College of Physicians 1, 2

First-Line Treatment

  • The American College of Physicians recommends nitrofurantoin (Macrobid) 100 mg twice daily for 5 days as the first-line treatment for uncomplicated urinary tract infections 3
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days has comparable efficacy to a 5-day regimen of nitrofurantoin, but should only be used if local resistance is less than 20%, as recommended by the Infectious Diseases Society of America and American College of Physicians 1
  • Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is recommended as a first-line treatment option for culture-positive cystitis, with minimal resistance patterns and limited collateral damage to gut flora, as suggested by the Infectious Diseases Society of America 1
  • Fosfomycin trometamol 3 g as a single dose is recommended as a first-line treatment option, although it has somewhat lower efficacy than other recommended agents, as suggested by the Infectious Diseases Society of America, American Urological Association, and European Society for Microbiology and Infectious Diseases 1, 4

Treatment Duration

  • The recommended treatment duration for uncomplicated cystitis is 3 days, with alternative options of 5-7 days, as suggested by the Infectious Diseases Society of America and American College of Physicians 1, 4
  • For complicated UTI or pyelonephritis, the recommended treatment duration is 7-14 days of therapy, as suggested by the Infectious Diseases Society of America 2
  • The following table summarizes the treatment duration for different conditions:
Condition Treatment Duration
Uncomplicated cystitis 3 days [1]
Uncomplicated cystitis (alternative) 5-7 days [4]
Complicated UTI or pyelonephritis 7-14 days [2]

Special Populations

  • Pregnant women with normal renal function can be treated with nitrofurantoin 100 mg twice daily for 5-7 days, as recommended by the American College of Obstetricians and Gynecologists 5, 6
  • Patients on hemodialysis with a urinary tract infection should be treated with trimethoprim-sulfamethoxazole at half the standard dose, administered after each dialysis session, as recommended by the Infectious Diseases Society of America and European Society for Microbiology and Infectious Diseases 7, 8

Prevention and Prophylaxis

  • Non-antibiotic alternatives like increased fluid intake (additional 1.5L daily) may help prevent recurrence of UTIs in elderly patients, as recommended by the American Urological Association 4
  • Antibiotic prophylaxis may be prescribed to decrease the risk of future UTIs, with options including nitrofurantoin 50-100 mg daily, trimethoprim 100 mg daily, or post-coital single dose when UTIs are related to sexual activity, as recommended by the American Urological Association and European Urology guidelines 9, 4

Treatment of Resistant UTIs

  • For UTIs caused by carbapenem-resistant Enterobacterales (CRE), treatment options include Ceftazidime-avibactam, meropenem-vaborbactam, imipenem-cilastatin-relebactam, or plazomicin, as recommended by 10

Monitoring and Adjustment

  • Clinical improvement should be assessed within 48-72 hours, and the treatment duration should be based on clinical response, as recommended by the American Medical Association 11

Contraindications and Precautions

  • Nitrofurantoin should be avoided in patients with suspected early pyelonephritis, renal impairment (GFR <30 ml/min), or infants less than 4 months of age due to the risk of hemolytic anemia, as recommended by the Infectious Diseases Society of America, American College of Obstetricians and Gynecologists, and European Urology guideline society 1, 5, 6, 12
  • Fosfomycin trometamol should be avoided if early pyelonephritis is suspected, as recommended by the Infectious Diseases Society of America 1
  • TMP-SMX should not be used if the local resistance rate exceeds 20%, the infecting strain is not susceptible, or if it has been used for UTI treatment in the previous 3 months, as recommended by the Infectious Diseases Society of America 1

REFERENCES